Circ_CHFR expedites cell growth, migration and inflammation in ox-LDL-treated human vascular smooth muscle cells via the miR-214-3p/Wnt3/β-catenin pathway

Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3282-3292. doi: 10.26355/eurrev_202003_20696.

Abstract

Objective: Atherosclerosis (AS) is a representative inflammatory vascular disease. This study explored the molecular pathogenesis of AS based on circular RNA (circRNA), the checkpoint with forkhead-associated and ring-finger domains (circ_CHFR).

Patients and methods: The cell model of AS in vitro was established by stimulating human vascular smooth muscle cells (VSMCs) with oxidized low-density lipoprotein (ox-LDL). The RNA expression was measured by quantitative Real-time polymerase chain reaction (qRT-PCR). Cell viability and colony formation ability were separately evaluated using 3-(4, 5-dimethylthiazol-2-y1)-2, 5-diphenyl tetrazolium bromide (MTT) and colony formation assay. Cell migration was assessed via the transwell assay. The inflammation injury was analyzed by enzyme-linked immunosorbent assay (ELISA). Associated proteins were determined through Western blot. The combination of hypothetic targets was ascertained using Dual-Luciferase reporter assay.

Results: Circ_CHFR was up-regulated in AS serums and ox-LDL-stimulated VSMCs. Circ_CHFR depletion weakened the ox-LDL-induced promotion of cell growth, migration and inflammation in VSMCs. Circ_CHFR positively regulated Wnt3 expression and the downregulation of Wnt3 abrogated the ox-LDL-triggered injuries in VSMCs. Circ_CHFR functioned as the sponge of microRNA-214-3p (miR-214-3p) and miR-214-3p targeted Wnt3. Circ_CHFR regulated cell growth, migration and inflammation via regulating the expression of Wnt3 as a competitive endogenous RNA (ceRNA) of miR-214 in ox-LDL-treated VSMCs. Circ_CHFR/miR-214-3p axis mediated the Wnt3/β-catenin signal pathway.

Conclusions: Circ_CHFR contributed to the progression of AS through the miR-214-3p/Wnt3/β-catenin signals, which illuminated the molecular mechanism of AS and suggested circ_CHFR might be an index for AS treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atherosclerosis / genetics
  • Atherosclerosis / pathology*
  • Cell Cycle Proteins / genetics*
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Cells, Cultured
  • Disease Progression
  • Humans
  • Inflammation / genetics
  • Inflammation / pathology*
  • Lipoproteins, LDL / administration & dosage
  • MicroRNAs / genetics
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / pathology
  • Myocytes, Smooth Muscle / cytology
  • Myocytes, Smooth Muscle / pathology
  • Neoplasm Proteins / genetics*
  • Poly-ADP-Ribose Binding Proteins / genetics*
  • RNA, Circular / genetics
  • Ubiquitin-Protein Ligases / genetics*
  • Wnt3 Protein / genetics
  • beta Catenin / metabolism

Substances

  • CTNNB1 protein, human
  • Cell Cycle Proteins
  • Lipoproteins, LDL
  • MIRN214 microRNA, human
  • MicroRNAs
  • Neoplasm Proteins
  • Poly-ADP-Ribose Binding Proteins
  • RNA, Circular
  • WNT3 protein, human
  • Wnt3 Protein
  • beta Catenin
  • oxidized low density lipoprotein
  • CHFR protein, human
  • Ubiquitin-Protein Ligases